巴西亚马逊州马瑙斯市新诊断HIV-1感染初治儿童的耐药情况
结果显示21.4%存在耐药突变,传播性耐药率为16.2%,最常见突变为E138A(8.5%),HIV-1亚型以B型为主(80.2%),C型占6.0%。
要点
- 初治HIV感染儿童中耐药突变患病率达21.4%,传播性耐药率为16.2%。
- 未报告PMTCT暴露的儿童中仍有近四分之一存在耐药突变。
- HIV-1亚型多样,C型扩张,需在亚马逊州开展亚型监测。
核心结论
- 该人群耐药突变患病率高,包括近四分之一未报告PMTCT暴露的儿童,高传播性耐药可能影响ART疗效。
- HIV-1多样性广泛且C型扩张,凸显亚马逊州亚型监测的必要性。
研究设计与样本
- 使用Calibrated Population Resistance Tool鉴定传播性耐药,通过Rega和系统发育分析定义HIV-1亚型。
主要发现
- 28.2%的儿童曾暴露于某种形式的PMTCT。
- 所有儿童中HIV耐药突变患病率为21.4%。
- PMTCT暴露儿童中,NRTI突变占3%,NNRTI突变占15.2%,PI突变占3%。
- PMTCT未暴露儿童中,NRTI突变占1.2%,非NNRTI突变占21.4%,PI突变占1.2%。
- 最常见耐药突变为E138A(8.5%);传播性耐药总患病率为16.2%,PMTCT暴露儿童为21.1%,未暴露儿童为14.3%。
关键数值与推荐
- HIV-1亚型分布:B型80.2%,C型6.0%,F1型3.4%,可能独特重组型10.3%(BF1 4.3%,DB 4.3%,BC 0.9%,KC 0.9%)。
临床怎么用
- 对初治HIV感染儿童启动ART前应考虑耐药检测,尤其在高传播性耐药地区。
- 需加强HIV-1亚型监测以指导疫苗和治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the prevalence of drug resistance mutations (DRM), the prevalence of drug susceptibility [transmitted drug resistance (TDR)] and the prevalence of HIV-1 variants among treatment-naive HIV-infected children in Manaus, Amazonas state, Brazil. METHODS: Children born to HIV-infected mothers and diagnosed with HIV in an HIV reference service centre and with available pol sequence between 2010 and 2015 prior to antiretroviral initiation were included. TDR was identified using the Calibrated Population Resistance Tool. HIV-1 subtypes were defined by Rega and phylogenetic analyses. RESULTS: One hundred and seventeen HIV-infected children with a median age of 3.7 years were included. Among them, 28.2% had been exposed to some form of prevention of mother-to-child transmission (PMTCT). HIV DRM were present in 21.4% of all children. Among PMTCT-exposed children, 3% had NRTI mutations, 15.2% had NNRTI mutations and 3% had PI mutations. Among PMTCT-unexposed children, 1.2% had NRTI mutations, 21.4% had non-NNRTI mutations and 1.2% had PI mutations. The most common DRM was E138A (8.5%). The prevalence of TDR was 16.2%; 21.1% among PMTCT-exposed children and 14.3% among PMTC-unexposed children. The analysis of HIV-1 subtypes revealed that 80.2% were subtype B, 6.0% were subtype C, 3.4% were subtype F1 and 10.3% were possible unique recombinant forms (BF1, 4.3%; DB, 4.3%; BC, 0.9%; KC, 0.9%). CONCLUSIONS: We report a high prevalence of DRM in this population, including in almost a quarter of children with no reported PMTCT. The high prevalence of TDR observed might compromise ART effectiveness. Results show extensive HIV-1 diversity and expansion of subtype C, which highlights the need for surveillance of HIV-1 subtypes in Amazonas state.
引用
- Andrade SD, Sabidó M, Monteiro WM, et al. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas. J Antimicrob Chemother. 2017. PMID: 28333295. doi:10.1093/jac/dkx025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。